Business Context and Reporting Period
This Form 6-K filing by AngloGold Ashanti plc, dated October 28, 2024, reports the results of the Court Meeting and General Meeting held to approve the recommended acquisition of Centamin plc. The transaction is structured as a court-sanctioned scheme of arrangement under Jersey law. The filing confirms that the requisite majorities were achieved to proceed with the acquisition, subject to final court sanction and other conditions.
Key Financial Metrics and Voting Results
The filing does not contain standard financial performance metrics such as revenue, profit, cash flow, or debt levels for AngloGold Ashanti or Centamin. Instead, it details the voting outcomes for the acquisition:
- Total Centamin Shares in Issue: 1,161,082,695
- Court Meeting Results: 98.08% of Scheme Shares voted were in favor (725,721,739 shares). This represented 62.50% of all eligible shares.
- General Meeting Results: 98.22% of votes cast were in favor of the Special Resolution approving the transaction.
- Quorum: Requisite quorums were present for both meetings.
Material Changes and Transaction Status
The primary material change is the successful shareholder approval of the acquisition of Centamin plc. The transaction is now proceeding toward the final stages of implementation. The filing notes that the transaction remains subject to the satisfaction or waiver of remaining conditions, most notably the sanction of the Scheme by the Jersey Court.
Guidance, Outlook, and Timetable
Management has provided an expected timetable for the completion of the transaction, contingent on the satisfaction of conditions:
- Scheme Court Hearing: Expected on November 20, 2024.
- Effective Date: Expected on November 22, 2024.
- Delisting and Listing: Centamin shares are expected to be delisted from the London Stock Exchange and Toronto Stock Exchange by November 25, 2024. New AngloGold Ashanti shares are expected to be listed on the Johannesburg Stock Exchange, A2X, New York Stock Exchange, and Ghana Stock Exchange on the same date.
- Share Issuance: New shares and cash consideration are expected to be credited to shareholders by December 6, 2024.
- Long Stop Date: February 28, 2025.
The filing includes extensive forward-looking statements and risk factors, noting that actual results may differ due to regulatory approvals, market conditions, commodity price fluctuations, and geopolitical risks in operating jurisdictions.
Investor Verification Checklist
- Verify the outcome of the Jersey Court Hearing scheduled for November 20, 2024, as this is a critical condition for the transaction.
- Confirm the final exchange ratio and consideration details in the Scheme Document, as this filing only reports voting results.
- Monitor announcements regarding the suspension of Centamin trading on the London Stock Exchange and Toronto Stock Exchange.
- Review the Scheme Document for specific tax implications for shareholders in their respective jurisdictions (UK, US, Canada, etc.).
- Check for any updates on the "Long Stop Date" of February 28, 2025, should the transaction face delays.